ArticlePDF Available

A Novel Anterior Cruciate Ligament Reconstruction Technique using LARS®-Augmented Autologous/Synthetic "Hybrid" Graft -High Re-Operation Rate in a Case-Control Study Corresponding author Medical & Clinical Research


Abstract and Figures

The paper compares hamstring autograft with a "hybrid" graft of hamstrings and a small LARS ligament in ACL reconstruction patients. The paper concludes ACLR utilizing a hybrid autologous/LARS® construct facilitated accelerated rehabilitation without evidence of increased failure or early graft stretch. Additionally, there was no clinical difference in functional outcome scores between the HYBRID and CONTROL groups. Although not statistically significant, the HYBRID group had an unacceptably high re-operation rate at 2-years post ACLR, and is therefore not recommended as a surgical technique by the primary author. The refinement of ACLR to facilitate patients’ safe and early return to previous levels of function presents a topic for future research.
Content may be subject to copyright.
Volume 5 | Issue 4 | 1Med Clin Res, 2020
A Novel Anterior Cruciate Ligament Reconstruction Technique using LARS®-Augmented
Autologous/Synthetic “Hybrid” Gra - High Re-Operation Rate in a Case-Control Study
Research Article
Fiona Stanley Hospital, 11 Robin Warren Drive, Murdoch 6150,
Western Australia, Australia
Perth Orthopaedic & Sports Medicine Centre, 31 Outram Street,
West Perth 6005, Western Australia, Australia
Royal Perth Hospital, 197 Wellington Street, Perth 6000Western
Australia, Australia
Levy Benjamin*1, Travis M Falconer2, Sheldon Moniz1, David Hille3 and Peter Annear2
*Corresponding author
Dr. Sheldon Moniz, Fiona Stanley Hospital, 11 Robin Warren Drive, Murdoch
6150, Western Australia, Australia
Submitted: 03 Apr 2020; Accepted: 08 May 2020; Published: 16 May 2020
Medical & Clinical Research
ISSN: 2577-8005
Anterior cruciate ligament reconstruction (ACLR) improves knee
function and stability in patients with ACL deficiency [1, 2].
Traditional ACLR rehabilitation programs recommend that
patients avoid returning to sports early to prevent graft stretch and
failure [3-6]. Earlier return to function, however, represents a
desirable clinical outcome.
After ACLR, the graft undergoes biological integration and
revascularization. In that period, the graft is temporarily
mechanically inferior to a mature graft, rendering it prone to graft
laxity [5, 7-12]. Historically, attempts at avoiding early laxity led
surgeons to perform ACLR with synthetic ligament substitutes.
The use of first-generation synthetic ligaments had universally
poor results with high rates of re-rupture and symptomatic
synovitis resulting from graft microparticalization [13-15]. A
systematic review by Newman et al, of modern, third-generation
synthetic grafts constructed of polyethylene terephthalate showed
lower rates of failure and synovitis at intermediate-term follow-up
Hybrid grafting using a combined synthetic/autologous graft is a
technique designed to facilitate accelerated rehabilitation (return
to sports at 2-6 months), and may offer an alternative to full
synthetic reconstruction. The superior mechanical properties of
the synthetic component may prevent graft stretching during
accelerated rehabilitation. The autologous component may provide
a lasting biological graft while enhancing biological ingrowth,
longevity, and safety of the prosthetic graft.
ACLR using a hybrid technique with combination autologous/
synthetic grafts within the same construct is a safe and satisfactory
option for patients with short or undersized donor grafts [17].
Furthermore, Hamido et al, published a retrospective study
demonstrating that patients with short or undersized hamstring grafts
that received reconstructions using similar hybrid grafts showed
superior knee stability compared with patients that received
reconstructions using autologous four-strand hamstring grafts [18].
The patients with the hybrid grafts also had a significant improvement
in International Knee Documentation Committee (IKDC) scores;
however, the rehabilitation program was not reported.
To our knowledge, no study has compared the clinical and
functional outcomes of hybrid ACLR combined with accelerated
rehabilitation against those of autologous ACLR combined with
conventional rehabilitation. Thus, the aim of this study was to
determine if faster rehabilitation can be achieved safely using a
hybrid ACL construct comprised of a hamstring auto graft and a
synthetic ligament (LARS–Ligament Augmentation Reconstruction
System, Corin Pty. Ltd.). Patient function, knee laxity, incidence
of failure, and complications were compared at a minimum of 2
years post-reconstruction.
We hypothesized that the use of a hybrid ACLR technique would
allow accelerated rehabilitation protocols, while protecting the
graft from early stretch or failure. Furthermore, we hypothesized
that patients that received hybrid ACLR would achieve objective
and subjective knee outcome scores and complication rates
comparable to those of patients that received autologous ACLR.
Additionally, we explored differences in the patient groups’
descriptive characteristics in choosing different grafts, as well as
unexpected differences in outcomes.
Materials and Methods
Enrolled Patients
Patients were considered if they underwent primary ACLR
performed by a single surgeon between August 2008 and February
2013. A total of 59 consecutive, consenting patients underwent
combined autologous/synthetic (HYBRID) ACLR. Forty-four
patients underwent primary autologous (CONTROL) ACLR. This
study was conducted with institutional ethics approval. Patients
included were skeletally mature, normally aligned, undergoing
primary ACLR not requiring concomitant ligament repair,
operated within six months of injury, and with an unaffected
contralateral knee. Patients with compensable knee injury were
excluded. After pre-operative counseling participants were given
the choice to receive either a hybrid graft with accelerated
rehabilitation or an autologous graft with a traditional rehabilitation
protocol. The patients’ demographic data are shown in Table 1.
The patient flow through the study is shown in (Figure 1). Volume 5 | Issue 4 | 2Med Clin Res, 2020
Figure 1
Assessment of eligibility
111patients consent to
hybrid LARS/autologous
44patients consent to
Lost to follow up n=20
Follow up
Total reviewed at 2 years n=91
Clinical review n=61
Clinicalexam & outcome measures n=59
(2 lost to follow up)
HYBRID cohort CONTROL cohort
autologous ACL
59patients did
not consent to
44patients followed
up at 2 years
Follow up
Clinicalexamination n=44
Outcomemeasures n=44
Figure 1
Propensity Score Matching (PSM) was undertaken, using Age and
Gender, in order to select a subset of the CONTROL group that is
matched to the HYBRID group. Of the 44 Control patients, 25
were used for matching to the 59 Hybrid Patient. Table 1.1 shows
a comparison of matched groups after PSM. The two groups are
no longer independent, and are therefore analysed as paired
Table 1: Descriptive Data
Control Hybrid
P value
n 44 59
Sex, female/male 26/18 18/41 .004a
Age at surgery, years
Mean ± SD
Median (range)
30.95 ± 11.82
27.19 (15.20 – 58.28)
32.03 ± 10.84
32.00 (14.84 – 53.27) .636b
Time to follow-up, years
Mean ± SD
Median (range)
2.51 ± 0.46
2.39 (1.90 – 3.91)
2.69 ± 0.64
2.46 (1.97 – 4.10) .099b
Age at follow-up, years
Mean ± SD
Median (range)
33.46 ± 11.60
30.35 (18.29 –
34.72 ± 10.85
34.66 (18.00 – 55.42) .576b
aChi-square test
bIndependent samples t test
cFisher’s exact test
Table 1.1: Descriptive Data after Matching
Matched Controls Hybrid
P value
n59 59
Sex, female/male 18/41 18/41 1.000a
Age at surgery, years
Mean ± SD
Median (range)
32.01 ± 10.85
33.24 (15.20 – 57.12)
32.03 ± 10.84
32.00 (14.84 – 53.27) .937b
Time to follow-up, years
Mean ± SD
Median (range)
2.46 ± 0.43
2.30 (1.92 – 3.91)
2.69 ± 0.64
2.46 (1.97 – 4.10) .027b
Age at follow-up, years
Mean ± SD
Median (range)
34.47 ± 10.58
35.53 (18.30 – 59.42)
34.72 ± 10.85
34.66 (18.00 – 55.42) .280b
aChi-square test
bPaired samples t test
Graft Constructs
Both the CONTROL and HYBRID groups of the study received
arthroscopic-assisted, four-tunnel anatomical double-bundle
ACLR using semitendinosis and gracilis tendons. Those who
received a HYBRID graft configuration had the anteromedial
bundle (AMB) augmented with a LARS prosthetic ligament
(Corin Group Product Code 104.133 “LARS anterior cruciate
reinforcement). The AMB was selected for augmentation because
it was considered able to withstand greater forces during early,
non-cutting, accelerated rehabilitation. Doubled gracilis tendon
was used in the posterolateral bundle (PLB) in both groups. The
prosthetic graft was added with the aim of stiffening the construct
to limit graft stretch or failure, as reported in previous studies
investigating accelerated rehabilitation programs in patients
undergoing autologous hamstring ACLR [5, 19-21]. In addition,
the combination of the synthetic graft with a native hamstring
tendon was intended to protect the knee from particulate wear by
encouraging biological ingrowth.
Surgical Technique
Arthroscopic-assisted, double-tunnel ACLR was performed as
previously described by Falconer et al [22, 23]. The patients in the
CONTROL group had the knee cycled 15 times with the graft
under maximal manual tension. The PLB was fixed at 20° flexion
using a Milagro Advance screw (DePuySynthes Pty. Ltd.). The
AMB was fixed at 45° flexion using an Intrafix screw
(DePuySynthes Pty. Ltd.). The patients in the HYBRID group had
the knee cycled ten times with the graft under maximum manual
tension. Both the AMB and the PLB were fixed in hyperextension
with maximal manual tension placed in the autograft components.
The LARS component was secured under minimal tension to
avoid over-constraining the knee.
Post-operative Rehabilitation
The CONTROL group patients underwent a conventional
rehabilitation protocol. The patients were permitted to bear weight
as tolerated in a resting splint for the first 2 weeks. Initial
rehabilitation focused on swelling reduction, knee range of motion,
and patella mobility. The brace was discontinued once the patients’
knee effusion had resolved. Pivoting activities and return to sport
commenced at 9–12 months post-operation. Volume 5 | Issue 4 | 3Med Clin Res, 2020
The HYBRID patients underwent an accelerated rehabilitation
protocol at a single rehabilitation center. The rehabilitation
protocol had a set timeline, although progression through the
program was individualized according to patients’ range of motion,
swelling, function, and pain. The program aimed to have the
patients performing pivoting/cutting movements at 16 weeks and
returning to sports at 6 months post-operation. Details of the
rehabilitation protocols are outlined in (Figure 2).
Figure 2 – Rehabilitation protocol
0-3 weeks
Resting extension splint
Crutch weight bearing
Inpatient exercises focused on regaining knee range of motion, patella
mobility, and swelling reduction
Cease use of brace once knee effusion resolved
6 weeks
Closed chain exercises
Stationary cycling
4 months
Progressing to change of
direction exercises and sport specific
exercises by 6 months
9 months
Commence full sport and
pivoting activities
8 weeks
Open Chain Exercises
4 months
Change of direction exercises
6 months
Commence full sport
Time Postoperatively
3-6 weeks as above 3-8 weeks
closed chain strengthening
Figure 2: Rehabilitation protocol
Clinical Assessment
All patients were followed up for a minimum of 2 years by a single
experienced physiotherapist. Subjective assessment included
Tegner Activity Score, Lysholm Knee Scale, IKDC Subjective
score, Cincinnati Knee Rating System, and ACL Quality of Life
Questionnaire (ACL QOL). Objective assessments included IKDC
objective scores, knee range of motion (ROM), presence of
effusion, and graft laxity KT-1000 instrumented arthrometry
(MEDmetric, San Diego, CA). Graft failure and the requirement
and cause for re-operation were also recorded.
Statistical Analysis
Results were analyzed using R statistical computing software and
IBM SPSS Statistics. Propensity Score Matching (PSM) was used
to select a subset of patients from the control group, with
replacement, that matched closest to the hybrid group. Paired
samples t-tests were used to compare means between continuous
variables. For some outcomes, the data failed to meet the
assumptions of the t test. In those cases, Wilcoxon Signed Rank
tests were used. Odds ratios, Chi-square tests, and Fisher’s exact
tests were used for categorical variables. Statistical significance
was considered when P<0.05.
There were no significant demographic differences between the
matched CONTROL group and the HYBRID group.
Subjective Comparisons: The IKDC Subjective was significantly
higher in the matched CONTROLS groups compared with the
HYBRID group (p = 0.013) There were no significant differences
found between the two matched groups across the other four
subjective knee scores (Table 2). Objective Comparisons: There
were no significant differences found between the two matched
groups for objective measures (Table 3). The KT-1000 side-to-side
difference mean for match CONTROLs was 0.94 mm and for
HYBRIDS was 0.46 mm.
Table 2.1: Subjective Clinical Comparisons
Outcome Matched Controls Hybrid P Value
Tegner 6.32 ± 2.10 6.41 ± 2.03 .723a
Cincinnati 371.61 ± 63.50 371.55 ± 41.41 .302b
Lysholm95 84.50 ± 14.72 85.72 ± 8.98 .555b
IKDC Sub. 88.46 ± 15.14 84.91 ± 11.60 .013b
ACL QOL 81.84 ± 18.12 79.96 ± 19.42 .434a
aPaired samples t test
bWilcoxon Signed Ranks test
KDC - International Knee Documentation Committee
ACL QOL – Anterior Cruciate Ligament Quality of Life Questionnaire
Table 3.1: Objective Knee Measures
Hybrid P Value
IKDC Objective, n (%)
41 (69%)
18 (31%)
0 (0%)
0 (0%)
36 (62%)
21 (36%)
1 (2%)
0 (0%)
Difference in ROM, Mean ± SD -3.25 ± 3.32 -2.10 ± 2.93 .056b
KT-1000 SSD (mm), Mean ± SD 0.94 ± 0.84 0.46 ± 1.66 .075c
SSD (<=3 mm) 98.3% 93.2% .364a
aFisher’s exact test
bWilcoxon Signed Ranks test
cPaired samples t test
SSD – Side-to-side difference
Complications/Return to Theatre
A summary of complications across both groups is detailed in
(Table 4).
Table 4: Complications
Hybrid Odds Ratio (95% CI)
Graft rupture 0 1 -
Graft laxity SSD > 3 mm 1 4 4.22 (0.46, 38.92)
Deep infection
11.84 (1.46, 95.75)
SSD – Side-to-side difference Volume 5 | Issue 4 | 4Med Clin Res, 2020
Graft failure and synovitis: In the matched CONTROL group,
there were no graft ruptures during the follow-up period. In the
HYBRID group one patient (1.8%) required surgical revision for
graft rupture at 34 months post ACLR. No patients in either group
had knee synovitis.
Re-operations: The odds ratio comparing reoperations between the
matched CONTROL group and the HYBRID group 11.84 (95% CI:
1.46, 95.75). Subdividing causes, the HYBRID group had a higher
rate of secondary meniscal surgery and arthrofibrosis surgery. The
subset of patients receiving re-operations was not large enough to
compute meaningful odds ratios. Among the matched CONTROLS,
there was one re-operations for symptomatic graft impingement
requiring arthroscopic notchplasty at four months post ACLR. In the
HYBRID group, there were ten re-operations (16.9%). One patient
(1.7%) was known to be immunocompromised and acquired a deep
infection. Four patients (6.8%) received surgical intervention for
menisco-chondral symptoms. A further four patients (6.8%) required
surgery for arthrofibrosis resulting in anterior knee pain and loss of
extension. Surgical intervention for arthrofibrosis consisted of notch
debridement with lateral retinacular release and was performed
within the first 12 months post ACLR. The odds ratio comparing
graft laxity between the matched CONTROL group and the
HYBRID group was not statistically significant. The outcomes of
the patients that returned to theatre are summarized in (Table 5).
Table 5: Clinical Features of Patients that Required Return to Theatre
Age (years) Sex Tegner IKDC
SSD (mm)
Cincinnati Lysholm95 ACL QOL Diff ROM
Arthrofibrosis surgery for loss of extension
CONT. Pt 23 21.6 F 6 81 B 2.7 350 78 82 0
HYBRID Pt 11 19.6 M 7 70 B -3.3 370 83 69 -7
HYBRID Pt 23 20.9 F 2 68 B -3.3 280 73 34 0
HYBRID Pt 40 27.1 M 5 59 A 1.7 360 87 75 0
HYBRID Pt 36 34.9 F 4 77 B 0.3 350 85 68 0
Arthroscopy for meniscal or chondral pathology
HYBRID Pt 20 21.9 F 6 72 B -1.7 350 73 46 0
HYBRID Pt 31 37.5 M 5 62 C 3.0 260 64 28 0
HYBRID Pt 32 33.5 M 5 67 B -1.0 280 76 40 -3
HYBRID Pt 50 50.2 F 5 85 A -2.0 290 93 66 -5
The CONTROL and HYBRID groups had similar subjective and
objective knee scores. HYBRID patients, however, had higher
rates of re-operation for arthrofibrosis and meniscal/chondral
complications, although the differences did not reach statistical
significance. There may be an indication for ACLR using hybrid
graft constructs in patients wishing to expedite their return to
sporting activities. The increased risk of re-operation, however,
must be taken into consideration.
Appropriate rehabilitation after ACLR is essential for achieving
optimal outcomes. Traditional ACL rehabilitation protocols avoid
loading the maturing graft for the first 3 months after surgery in an
attempt to prevent graft stretch and early rupture [5, 6, 24, 25].
Studies allowing running before 2 months report increased laxity
and graft failure [21, 24]. A synthetic graft in conjunction with an
autologous ACL may protect the graft, allowing for safe,
accelerated rehabilitation.
Synthetic grafts have been employed in ACLR since the 1980s in
an attempt to achieve immediate tensile strength, reduce surgical
time, reduce donor-site morbidity, and allow earlier return to
previous function. Formerly used synthetic grafts included Dacron
Ligament Prosthesis, Leeds-Keio, Kennedy Ligament
Augmentation Device (LAD), and GORE- TEX. The outcomes of
those grafts were universally poor with high reported rates of graft
failure and synovitis [13, 26, 27].
The LARS® artificial ligament is manufactured from terephthalic
polyethylene polyester. Its porosity is proposed to create favorable
conditions for biological ingrowth, in turn decreasing the incidence of
reactive synovitis [28]. Trieb et al, demonstrated the capacity of the
LARS® ligament to encourage complete fibroblastic/osteoblastic
ingrowth within in vivo and in vitro settings at six months post-
implantation [29]. Important surgical techniques described when
using the LARS include remnant sparing, tensioning in extension, and
avoidance of impingement [22, 30, 31]. Stiffness characteristics may
be important for the autograft for limiting stress shielding and allowing
satisfactory ligamentization, thereby enhancing long-term function.
A combined LARS/hamstring hybrid graft coupled with
accelerated rehabilitation has not been previously compared with
hamstring grafts. Hamido et al compared a similar hybrid graft
with a hamstring graft cohort [18]. Their study differed, as both
grafts were single bundle, the hybrid was indicated only for
patients with small hamstrings, and recovery times were not
assessed. That study showed that hybrid patients had improved
KT-1000 stability (1.1 ± 0.3 mm vs 2.5 ± 0.5 mm; p<0.05) and
higher rates of objective IKDC A and B scores (96% vs 71%;
p<0.05) at 5 years follow-up. This is in contradiction to our study,
as we found no difference in objective knee scores. We chose a
double-bundle graft for each cohort as our preferred technique,
which may explain more stable knee scores in the hamstring group
(KT-1000 - 0.9 mm: combined IKDC A and B - 95%). Volume 5 | Issue 4 | 5Med Clin Res, 2020
Brunet et al studied the outcomes of acute posterior cruciate
ligament (PCL) tears reconstructed using a hybrid construct
similar to that used in our study [32]. They described the LARS®
ligament as functioning as “a tutor” for healing the PCL, similar to
our proposal for the ACL.
The higher number of re-operations in the HYBRID group was not
expected. Although it was not statistically significant, the relatively
high incidence of re-operation in the HYBRID group is of concern.
Ten patients (16.9%) in the HYBRID group required re-operation
within 2 years following ACLR. Four patients required surgery for
menisco-chondral pathology and four required arthroscopic
intervention for loss of extension/anterior knee pain. Those
patients had lower IKDC subjective scores and slower recovery
times compared with the averages across the study. The reason for
the high rate of re-operations has not been definitively established.
The augmentation of the autologous graft with a relatively inelastic
synthetic graft and a fixed working length may have contributed to
a loss of extension. Additionally, the four-tunnel ACLR and
remnant-sparing technique used in our study may have contributed
to excessive graft constraint [33, 34]. Retention of the remnant
tissue may also cause graft/notch impingement by increasing the
remnant volume. It may be that the use of synthetic grafts and
aspects of the surgical technique noted above resulted in excessive
graft constraint with associated loss of extension. Finally, we
adopted a surgically aggressive approach to patients struggling to
achieve full extension, which may reflect our high re-operation
The development of arthrofibrosis following ACLR can have
debilitating effects on knee function. Studies have shown its
potential to disrupt normal knee kinematics and lead to early
progression of degenerative joint disease [35-37]. Mayr et al,
found radiological evidence of degenerative joint disease in 88.2%
of patients with arthrofibrosis after ACLR [38]. It is currently
unknown if there is a link between over-constraint of the knee and
arthrofibrosis. We have changed our practice to performing single
bundle HYBRID ACLR due to concerns of re-operation rates,
arthrofibrosis, and knee over-constraint.
There were no adverse effects of stress shielding on the autologous
component of the hybrid graft in our study. Yoshiya et al, found
that the presence of a synthetic graft within a hybrid construct
adversely affected the ability of the construct to re-vascularize
over time. Yoshiya et al, went on to find that excessive synthetic
graft stress shielding resulted in weaker, looser grafts in canine
subjects. Similarly, McCarthy et al demonstrated that stress
shielding results in prolonged graft remodeling and a decreased
load to failure. Our graft stability and low failure rates at 2 years
may suggest stress shielding is unlikely; however, long-term
studies are required to definitively assess this [39-41].
Selection bias may have influenced the outcomes of our study.
More motivated patients may have a tendency to opt for graft
types that facilitate an expedient return to sports. They may be
more diligent in rehabilitation and/or may take more risks to
achieve the perceived benefit of earlier return to sports. In the
current study, participants were recruited in a private-practice
setting and chose their preferred graft type with its associated
rehabilitation program. This prevented us from being able to
randomize patients into groups. A randomized controlled trial
would more clearly illustrate the impact of augmented graft
constructs coupled with accelerated rehabilitation programs,
however, this may be problematic from an ethical standpoint. We
attempted to address this using propensity score matching.
Unfortunately, given the number of controls available for matching
and the subset subsequently matched, the analysis is likely to be
underpowered [21].
The comparison of both different rehabilitation protocols and a
different surgical techniques between groups may have introduced
bias and hindered our ability to draw accurate conclusions
regarding outcomes. However, our study hypothesis aimed to
investigate a “graft plus rehabilitation” comparison as the graft /
rehabilitation combination was intended to complement one
another. In the study design phase, it was deemed unacceptable to
accelerate the rehabilitation of the CONTROL group due to the
risk of early graft damage.
The short-term follow-up limits analysis of the effects of stress
shielding and knee over-constraint in the HYBRID group. Longer
follow-up is required to evaluate this fully. Additionally, exclusion
of patients who received ACLR more than six months from injury
may have contributed to bias.
ACLR utilizing a hybrid autologous/LARS® construct facilitated
accelerated rehabilitation without evidence of increased failure or
early graft stretch. Additionally, there was no clinical difference in
functional outcome scores between the HYBRID and CONTROL
groups. Although not statistically significant, the HYBRID group
had an unacceptably high re-operation rate at 2-years post ACLR,
and is therefore not recommended as a surgical technique by the
primary author. The refinement of ACLR to facilitate patients’ safe
and early return to previous levels of function presents a topic for
future research.
1. Larson RL, Taillon M (1994) Anterior Cruciate Ligament
Insufficiency: Principles of Treatment. Journal of the
American Academy of Orthopaedic Surgeons 2: 26-35.
2. Prodromos CC, Han YS, Keller BL, Bolyard RJ (2005)
Stability results of hamstring anterior cruciate ligament
reconstruction at 2- to 8-year follow-up. Arthroscopy 21: 138-
3. G Myklebust RB (2005) Return to play guidelines after
anterior cruciate ligament surgery. British Journal of Sports
Medicine 39: 127-131.
4. Kvist J (2004) Rehabilitation Following Anterior Cruciate
Ligament Injury. Sports Medicine 34: 269-280.
5. Fujimoto E SY, Urabe Y (2004) An early return to vigorous
activity may destabilize anterior cruciate ligaments
reconstructed with hamstring grafts. Archives of Physical
Medicine and Rehabilitation 85: 298-302.
6. Anderson AF, Lipscomb AB, Liudahl KJ, Addlestone RB
(1987) Analysis of the intercondylar notch by computed
tomography. The American journal of sports medicine 15:
547-552. Volume 5 | Issue 4 | 6Med Clin Res, 2020
7. Ballock RT WS, Lyon RM, Hollis JM, Akeson WH (1989)
Use of patellar tendon autograft for anterior cruciate ligament
reconstruction in the rabbit: a long-term histologic and
biomechanical study. Journal of Orthopaedic Research 7: 474-485.
8. Beynnon BD JR, Toyama H, Renström PA, Arms SW, Fischer
RA (1994) The relationship between anterior-posterior knee
laxity and the structural properties of the patellar tendon graft.
A study in canines. American Journal of Sports Medicine 22:
9. Fujimoto E, Sumen Y, Urabe Y, Deie M, Murakami Y, et al.
(2004) An early return to vigorous activity may destabilize
anterior cruciate ligaments reconstructed with hamstring grafts.
Archives of Physical Medicine and Rehabilitation 85: 298-302.
10. Howell Lcsm, Taylor CMA (1996) Brace-Free Rehabilitation,
with Early Return to Activity, for Knees Reconstructed with a
Double-Looped Semitendinosus and Gracilis Graft. The
Journal of Bone &amp; Joint Surgery 78: 814-825.
11. Leys T, Salmon L, Waller A, Linklater J, Pinczewski L (2012)
Clinical Results and Risk Factors for Reinjury 15 Years After
Anterior Cruciate Ligament Reconstruction: A Prospective
Study of Hamstring and Patellar Tendon Grafts. The American
Journal of Sports Medicine 40: 595-605.
12. Salmon L, Russell V, Musgrove T, Pinczewski L, Refshauge
K (2005) Incidence and Risk Factors for Graft Rupture and
Contralateral Rupture After Anterior Cruciate Ligament
Reconstruction. Arthroscopy: The Journal of Arthroscopic &
Related Surgery 21: 948-957.
13. Vergis A JG (1995) Graft failure in intra-articular anterior cruciate
ligament reconstructions: A review of the literature. Arthroscopy:
The Journal of Arthroscopic & Related Surgery 11: 312-321.
14. Prescott R, Ryan W, Bisset D (1994) Histopathological
features of failed prosthetic Leeds-Keio anterior cruciate
ligaments. Journal of clinical pathology 47: 375-376.
15. Olson EJ, Kang JD, Fu FH, Georgescu HI, Mason GC, et al.
(1988) The biochemical and histological effects of artificial
ligament wear particles: in vitro and in vivo studies. The
American journal of sports medicine 16: 558-570.
16. Newman SD, Atkinson HD, Willis-Owen CA (2013) Anterior
cruciate ligament reconstruction with the ligament
augmentation and reconstruction system: a systematic review.
International orthopaedics 37: 321-326.
17. Hamido F, Misfer A, Al Harran H, Khadrawe T, Soliman A, et
al. (2011) The use of the LARS artificial ligament to augment
a short or undersized ACL hamstrings tendon graft. The Knee
18: 373-378.
18. Hamido F AHH, Al Misfer AR, El Khadrawe T, Morsy MG, et
al. (2015) Augmented short undersized hamstring tendon graft
with LARS® artificial ligament versus four-strand hamstring
tendon in anterior cruciate ligament reconstruction:
preliminary results. Orthopaedics & traumatology, surgery &
research. OTSR 101: 35-38.
19. Howell SM, Hull ML (1998) Aggressive rehabilitation using
hamstring tendons: graft construct, tibial tunnel placement,
fixation properties, and clinical outcome. The American
journal of knee surgery 11: 120-127.
20. Salmon L RV, Musgrove T, Pinczewski L, Refshauge K (2005)
Incidence and risk factors for graft rup- ture and contralateral
rupture after anterior cruciate ligament reconstruction.
Arthroscopy 21: 948-957.
21. Pinczewski L, Lyman, J, Salmon, L, V Russell, V Roe, et al.
(2007) A 10-year comparison of anterior cruciate ligament
reconstructions with hamstring tendon and patellar tendon
autograft: A controlled, prospective trial. American Journal of
Sports Medicine 35: 564-574.
22. Falconer T TL, Breidahl W, Annear P (2015) The LARS
augmented 4-tunnel hamstring “hybrid” ACLR graft
construction allows accelerated rehabilitation without knee
laxity - Case series of 111 patients after 2 years. Journal of
Musculoskeletal Research 18: 1550020.
23. Falconer T GS, Tusak L, Breidahl W, Annear P (2016) Tunnel
positioning in remnent sparing double bundle ACL
reconstruction - A 2-year study of MRI tunnel positions,
clinical outcomes and tunnel confluence. Journal of
Musculoskeletal Research 19: 1650004-1650019.
24. Howell ST MA (1996) Brace-free rehabilitation, with early
return to activity, for knees reconstructed with a double-
looped semitendinosus and gracilis graft. Journal of Bone &
Joint Surgery American 78: 814-825.
25. Leys T SL, Waller A, Linklater J, Pinczewski L (2012) Clinical
results and risk factors for reinjury 15 years after anterior
cruciate ligament reconstruction: A pro- spective study of
hamstring and patellar tendon grafts. American Journal of
Sports Medicine 40: 595-605.
26. George MS DW, Spindler KP (2006) Current concepts review:
revision anterior cruciate ligament reconstruction. American
Journal of Sports Medicine 34: 2026-2037.
27. Freeman JW WM, Laurencin CT (2007) Tissue Engineering
of the Anterior Cruciate Ligament Using a Braid-Twist
Scaffold Design. Journal of Biomechanics 40: 2029-2036.
28. Trieb K, Blahovec H, Brand G, Sabeti M, Dominkus M, et al.
(2004) In vivo and in vitro Cellular Ingrowthinto a New
Generation of Artificial Ligaments. European surgical
research 36: 148-151.
29. Trieb K BH, Brand G, Sabeti M, Dominkus M, Kotz R (2004)
In vivo and in vitro cellular ingrowth into a new generation of
artificial ligaments. European Surgical Research 36: 148-151.
30. Falconer T, Dabirrahmani D, Tusak L, Pollock J, Breidahl B,
et al. Comparison of Hamstring and Lars Hamstring
Augmentation Double Bundle.
31. Tiwari SR, Cheng B (2017) Research Advances in Anterior
Cruciate Ligament Reconstructions with Remnant
Preservation: A Review Article. Biomedical Letters 3: 71-78.
32. Brunet P CO, Degeorges R, Boisrenoult P, Beaufils P (2005)
Reconstruction of acute posterior cruciate ligament tears
using a synthetic ligament. Revue de Chirurgie Orthopedique
et Traumatologique 91: 34-43.
33. Gohil S AP, Breidahl W (2007) Anterior cruciate lig- ament
reconstruction using autologous double ham- strings: A
comparison of standard versus minimal debridement Volume 5 | Issue 4 | 7Med Clin Res, 2020
techniques using MRI to assess revascu- larisation. A
randomised prospective study with a one- year follow-up.
Journal of Bone & Joint Surgery, British 89: 1165-1171.
34. Weiler A PG, Mäurer J, Unterhauser FN, Süd- kamp NP
(2001) Biomechanical properties and vascularity of an anterior
cruciate ligament graft can be predicted by contrast-enhanced
magnetic resonance imaging. A two- year study in sheep.
American Journal of Sports Medicine 29: 751-761.
35. Pan X WH, Wang L, Ge T (2013) Bone-patellar tendon- bone
autograft versus LARS artificial ligament for an- terior
cruciate ligament reconstruction. European Journal of
Orthopaedic Surgery & Traumatology 23: 819-823.
36. Gao K CS, Wang L, Zhang W, Kang Y, Dong Q, et al. (2010)
Anterior cruciate ligament reconstruction with LARS artificial
ligament: A multicenter study with 3- to 5-year follow-up.
Arthroscopy: The Journal of Arthroscopic & Related Surgery
26: 515-523.
37. Paulos LE RT, Drawbert J, Manning J, Abbott P (1987)
Infrapatellar contracture syndrome. An unrecognized cause of
knee stiffness with patella entrapment and patella infera.
American Journal of Sports Medicine 15: 331-341.
38. Mayr HO WT, Plitz W (2004) Arthrofibrosis following ACL
reconstruction—reasons and outcome. Archives of orthopaedic
and trauma surgery 124: 518-522.
39. Yoshiya S AJ, Manley M, Masahiro K (1986) Augmentation
of anterior cruciate ligament reconstruction in dogs with
prostheses of different stiffness. Journal of Orthopaedic
Research 4: 475-485.
40. Yoshiya S AJ, Manley M, Bauer T (1987) Graft tension in
anterior cruciate ligament reconstruction an in vivo study in
dogs. American Journal of Sports Medicine 15: 464-470.
41. McCarthy J SJ, Dunlap J, Shively R, Stonebrook S (1990) A
nonparallel, non-isometric synthetic graft augmentation of a
patellar tendon anterior cruciate ligament reconstruction. A
model for assessment of stress shielding. The American
journal of sports medicine 18: 43-49.
Copyright: ©2020 Sheldon Moniz, et al. is is an open-access article
distributed under the terms of the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are credited.
ResearchGate has not been able to resolve any citations for this publication.
Full-text available
Purpose: The purpose of this study is to examine the outcomes of a cohort of patients who have undergone a new surgical technique for anterior cruciate ligament (ACL) tunnel targeting using the footprint of the torn ACL as soft tissue markers. This is in the setting of anatomical ACLR with remnant preservation. Methods: This retrospective single center cohort study was conducted on patients undergoing a primary ACLR between August 2008 and February 2013. A total of 103 patients underwent ACLR with a remnant sparing technique with non-radiological soft tissue targeting of femoral and tibial tunnels. Exclusion criteria included skeletal immaturity, concomitant meniscal repair or ligament surgery, knee malalignment, delayed presentation ((Formula presented.)6 months post injury) and incomplete medical insurance. At 2 years all patients had gadolinium MRI scan, plain film X-ray, and a clinical assessment including KT-1000 arthrometry, and the following outcome scores; Tegner, IKDC (subjective/objective), Lysholm, Cincinnati and ACL Quality of Life. Results: A total of 44 patients (18 males, 26 females; mean age 30.9 years (Formula presented.)/(Formula presented.)11.8) were enrolled within the study. About 93.2% of the participants achieved an IKDC objective rating of A or B. The mean scores for outcome measures were; IKDC Subjective (84.9(Formula presented.)(Formula presented.)/(Formula presented.)(Formula presented.)11), Tegner (6.1(Formula presented.)(Formula presented.)/(Formula presented.)(Formula presented.)2), Lysholm (87.2(Formula presented.)(Formula presented.)/(Formula presented.)(Formula presented.)11.3), Cincinnati (358.1(Formula presented.)(Formula presented.)/(Formula presented.)(Formula presented.)40.8) and ACL Quality of Life (75.4(Formula presented.)(Formula presented.)/(Formula presented.)(Formula presented.)19). There were no graft failures at follow up. No patients had a loss of full extension (Formula presented.). All tunnels were positioned satisfactorily. Almost half of all femoral tunnels (47.8%) and 30.4% of tibial tunnels were confluent at the joint surface. Conclusions: This series demonstrates that anatomical double tunnel ACLR using non-radiological guided remnant retention technique, provides satisfactory 2-year clinical outcomes and is a safe and effective option. Targeting tunnels to be within the native remnant leads to high rates of tunnel confluence.
Full-text available
Purpose: The Ligament Augmentation and Reconstruction System (LARS) is a third generation of synthetic ligament, designed to overcome the issues of graft failure and synovitis which led previous generations of synthetic ligaments to fall out of favour. The theoretical benefits of LARS are appealing but this has not led to widespread uptake of the system in preference to autograft. The aim of this systematic review is to assess whether the evidence exists to support the use of LARS with respect to outcomes and complications. Methods: A systematic search process was undertaken from January 1990 to June 2012 to identify primary evidence relating to the use of LARS in anterior cruciate ligament (ACL) single ligament reconstruction. Results: Nine studies were found meeting the search criteria including a single randomised controlled trial, two comparative series and six further observational case series. Overall the methodological quality of the studies was poor with follow-up to a maximum of five years. Reported outcome scores were good for LARS and comparable to autograft techniques. Complication rates were low and comparable to those published for autograft techniques within the wider literature. Two reported incidences of synovitis were identified in case reports. Conclusions: The current literature supports the use of LARS in the short to medium term. However, high-quality studies with long-term follow-up are required to determine whether the use of LARS is preferable to autograft for ACL reconstruction over the longer term. Synovitis appears to be a rare complication closely related to imperfect graft positioning.
Full-text available
The aim of this study is to evaluate the midterm results of using Ligament Advanced Reinforcement System (LARS) artificial ligament for augmentation of the short (<15 cm length) and small-sized (3-4 mm) diameter for the gracilis and (4-5 mm) for the semitendinosus harvested hamstring tendons in anterior cruciate ligament (ACL) reconstruction, and to assess the knee stability, patient satisfaction and early- and midterm complications following surgery. A total of 112 patients were included in this study and were operated with arthroscopic ACL reconstruction using (augmented hamstring tendon graft with LARS) between January 2004 and December 2006. Assessment before and after the surgery include the history, clinical examination, modified international knee documentation committee score (IKDC), KT1000 measurements for clinical knee stability and osteoarthritis outcome score (KOOS) for patient satisfaction. Clinical results measured by IKDC evaluation, KT1000 and Lysholm scores showed significant postoperative values compared with the preoperative ones. Our findings suggest that at the end of a 5-year follow-up, augmented hamstring tendon graft with LARS artificial ligament is a useful, safe and satisfactory treatment option for ACL reconstruction in deficient knees with short- and small-sized harvested hamstring tendons, especially when an early return to high levels of sport activity is needed.
Anterior cruciate ligament (ACL) injuries often result in functional disability, particularly in jumping, cutting, and deceleration activities. Some patients can accommodate to this functional loss, while others require surgical reconstruction of the ligament to provide stability and to protect the meniscus from further injury. Nonoperative management involves an intensive rehabilitation program, patient counseling about high-risk activities, and measures to prevent recurrent injuries. Surgical reconstruction of the ACL involves the technical factors of graft selection, positioning, fixation, and tensioning and the avoidance of stress risers. A supervised and intensive rehabilitation program is necessary to achieve optimal results.
There is a lack of prospective studies comparing the long-term outcome of endoscopic anterior cruciate ligament (ACL) reconstruction with either a patellar tendon or hamstring tendon autograft. This prospective longitudinal study compared the results of isolated endoscopic ACL reconstruction utilizing a 4-strand hamstring tendon (HT) or patellar tendon (PT) autograft over a 15-year period with respect to reinjury, clinical outcomes, and the development of osteoarthritis. Cohort study; Level of evidence, 2. Ninety consecutive patients with isolated ACL rupture were reconstructed with a PT autograft, and 90 patients received an HT autograft, with an identical surgical technique. Patients were assessed at 2, 5, 7, 10, and 15 years. Assessment included the International Knee Documentation Committee (IKDC) knee ligament evaluation including radiographic evaluation, KT-1000 arthrometer testing, and Lysholm knee score. Patients who received the PT graft had significantly worse outcomes compared with those who received the HT graft at 15 years for the variables of radiologically detectable osteoarthritis (grade A: 46% in PT and 69% in HT; P = .04), motion loss (extension deficit <3°: 79% in PT and 94% in HT; P = .03), single-legged hop test (grade A: 65% in PT and 92% in HT; P = .001), participation in strenuous activity (very strenuous or strenuous: 62% of PT and 77% of HT; P = .04), and kneeling pain (moderate or greater pain: 42% of PT and 26% of HT; P = .04). There was no significant difference between the HT and PT groups in overall IKDC grade (grade A: 47% of PT and 57% of HT; P = .35). An ACL graft rupture occurred in 17% of the HT group and 8% of the PT group (P = .07). An ACL graft rupture was associated with nonideal tunnel position (odds ratio [OR], 5.0) and male sex (OR, 3.2). Contralateral ACL rupture occurred in significantly more PT patients (26%) than HT patients (12%) (P = .02) and was associated with age ≤18 years (OR, 4.1) and the PT graft (OR, 2.6). Anterior cruciate ligament reconstruction using ipsilateral autograft continues to show excellent results in terms of patient satisfaction, symptoms, function, activity level, and stability. The use of HT autograft does, however, show better outcomes than the PT autograft in all of these outcome measures. Additionally, at 15 years, the HT graft-reconstructed ACLs have shown a lower rate of radiological osteoarthritis.
The potential for a rigidly fixed synthetic graft placed in the over-the-top position to be stress shielding/stress sharing with the patellar tendon autograft was as sessed in a primate model. A patellar tendon autograft was placed anatomically and tensioned at 2 pounds for all of the groups. In the augmented animals, a 30 strand braided graft 10 cm in length of expanded polytetra fluoroethylene was tightened with the knee in full ex tension. After 6 months of unrestricted cage activity the animals were sacrificed and biomechanical testing performed. The augmented patellar tendon autografts demonstrated less laxity in extension as compared to the autografts alone. A minimal decrease in the load and stiffness to failure for the augmented groups as compared to the nonaugmented knees was noted. However, both the reconstruction groups had a signif icant decrease in the load to failure at 6 months (50% of the normal ACL). In summary, this study demonstrated that a synthetic graft augmentation can be performed in the over-the- top position and minimize knee laxity, especially during terminal extension. With this technique, the laxity was minimized while the incorporation and strengthening of the biologic autograft occurred at a rate similar to the unaugmented reconstruction.
Growing evidence suggests that biochemical mecha nisms play a role in the pathogenesis of arthritis. Car tilaginous wear particles have been shown to induce destructive enzymes and cytokines. To assess the biocompatibility of artificial ACL replacements, the ef fects of wear particles from the following ligaments were analyzed biochemically and histologically: GORE- TEX, Stryker Dacron Ligament Prosthesis, Versigraft carbon, Kennedy LAD, Xenograft, Leeds-Keio, and hu man patellar tendon allograft. Ligaments were frozen and ground to produce wear particles similar to those seen clinically and were added to lapine synovial cell cultures. The resulting conditioned medium was ana lyzed for collagenase, gelatinase, and chondrocyte ac tivating factor (CAF) production. All of the ligaments induced significantly elevated enzyme and CAF production by the synoviocytes, with Xenograft and carbon inducing significantly higher en zyme levels than those of the other five ligaments. Five milligrams of wear particles were injected into the knees of 4 kg to 5 kg rabbits that were analyzed histologically after 14 weeks. Wear particles accumu lated in the periarticular synovial folds and induced modest to severe macrophage infiltration in the syno vium. A hypothetical model explaining the role of artifi cial ligament wear particles in the pathogenesis of arthritis is presented.
The purpose of this study was to investigate the biological and biomechanical properties of anterior cruciate ligament (ACL) reconstruction augmented with Dacron prostheses of three different stiffnesses. The ACLs of 36 adult mongrel dogs were removed and the ligament was reconstructed. In 18 dogs, one knee was reconstructed with patellar tendon alone, and the contralateral knee with Dacron augmented patellar tendon. In the remaining 18 dogs, reconstruction was with Dacron augmented patellar tendon with Dacron alone being used for the contralateral control knee. Death was 3 months after surgery, and the reconstructions were examined biologically and biomechanically. The mechanical data were compared with immediate postoperative data obtained from 45 reconstructed fresh cadaveric knees. Tensile testing demonstrated that an increase in failure load was found when the implanted patellar tendon graft was compared with the cadaveric reconstruction. The strength of the Dacron augmented reconstruction showed little change while the Dacron alone graft decreased in strength during the period of implantation. No clear difference was found between the performance of augmentation devices of different stiffnesses. Microangiography showed that grafts were totally revascularized in patellar tendon alone, but not well revascularized in Dacron augmented patellar tendon and Dacron alone reconstruction. The presence of the Dacron appeared to have an adverse effect on revascularization.
The purposes of this study were to document the dimensions and configuration of the intercondylar notch in the normal knee; to compare normal knee intercondylar notches to those of knees with unilateral and bilateral ACL tears to determine if there is a relationship between intercondylar notch stenosis and ACL tears; and to determine if generalized ligamentous laxity is associated with intercondylar notch stenosis and ACL tears. Three groups were compared: Group I, bilateral ACL tears; Group II, unilateral tears; and Group III, normal knees. Notch dimensions were computer-generated from CT scans. All patients were examined for ligamentous laxity. Statistically significant differences were found between normal and ACL-injured knees in regard to opening notch angle, ratio of notch width at two-thirds of the notch length to condylar width, and ratio of maximum notch width to condylar width, suggesting a significant association between anterior outlet stenosis and unilateral and bilateral ACL tears. The shapes of the notches were determined from tracings of the distal CT scan. Shapes ranged from inverted U to cresting wave. Narrow notches tended to be waveshaped, but more study is needed in this area. Notch-plasty is recommended for those with documented stenosis. The ratio of maximum notch width at two-thirds of the notch height to maximum condyle width should not be much less than 0.2, and the opening notch angle should be at least 50 degrees.
Infrapatellar Contracture Syndrome (IPCS) is an infre quently recognized cause of posttraumatic knee mor bidity. Unique to this group of patients is the combina tion of restricted knee extension and flexion associated with patella entrapment. IPCS can occur primarily as an exaggerated pathologic fibrous hyperplasia of the anterior soft tissues of the knee beyond that associated with normal healing. It can also occur secondarily to prolonged immobility and lack of extension associated with knee surgery, particularly intraarticular ACL recon struction. IPCS follows a predictable natural history which is divided into three stages. Symptoms, diagnos tic findings, and recommended treatment are deter mined by the stage at presentation. Once beyond its early presentation, IPCS is best treated by an anterior intraarticular and extraarticular capsular debridement and release, followed by extensive rehabilitation. The authors review 28 consecutive cases of IPCS. At fol lowup 3 months to 4 years postoperation, the patients had averaged 2.3 additional surgical procedures follow ing their index procedure or injury. The average increase in extension at followup was 12° with the average increase flexion 35°. Eighty per cent of patients demonstrated signs and symptoms consistent with patellofemoral arthrosis; 16% of the patients demonstrated patella infera. The authors con clude that prevention or early detection and aggressive treatment are the only ways of avoiding complication in these problem cases.